Purchase Order W81K0020P0267
Award Date 9/8/20
Potential Completion Date 8/31/25
Potential Value $3.2M
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a Blanket Purchase Agreement call valued at $74,945.52 to Phadia US Inc.'s Immunodiagnostics Division on August 22, 2025, with completion targeted for September 30, 2025. Under this firm fixed-price contract, Phadia will supply reagents and conduct allergy testing services for San Antonio Military Medical Center and 153 additional military treatment facilities across the Department of Defense. This testing provides critical diagnostic information to healthcare...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The BPA call is for allergy and asthma testing solutions, including analyzers, reagents, and consumables to support military medical readiness and research programs. Phadia US Inc. has been the sole source provider for many similar MEDCOM contracts due to its proprietary products being the only...
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the delivery of $146,363.76 in allergen detection equipment and reagents. Phadia is a provider of allergy and autoimmune testing solutions, and has previously supplied allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support their medical readiness...
- The Defense Health Agency awarded a Blanket Purchase Agreement call valued at $49,921.55 to Phadia US Inc.'s Immunodiagnostics Division on July 23, 2025, with completion targeted for September 30, 2025. Under this firm fixed-price contract, Phadia will supply allergy testing reagents to support healthcare providers across the San Antonio military treatment facility and 153 additional military medical installations. The reagents are essential for detecting and managing allergic reactions across...
- The Defense Health Agency (DHA) awarded Phadia US Inc.'s Immunodiagnostics Division a $24,142.06 Blanket Purchase Agreement (BPA) call on August 16, 2025, for allergy testing reagents to be delivered to Portage, Michigan by September 30, 2025. This firm fixed-price contract represents an open market procurement with no set-aside designation. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, specializes in advanced immunodiagnostic solutions and has established itself as a...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- The Defense Health Agency awarded a $20,580 firm-fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on August 26, 2025, with completion targeted for September 30, 2025. This contract procures allergen-specific immunoglobulin E (IgE) reagents essential for allergy testing and management across the San Antonio military treatment facility and 153 additional military healthcare installations. The reagent supply supports critical diagnostic capabilities...
- The Defense Health Agency awarded Phadia US Inc.'s Immunodiagnostics Division a $24,960.42 firm fixed-price Blanket Purchase Agreement call for laboratory equipment on June 17, 2025, with an ultimate completion date of September 30, 2025. The contract, which does not utilize a set-aside designation, will be performed in Portage, Michigan. As a foreign-owned subsidiary of Thermo Fisher Scientific, Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing...
- The Department of the Army Medical Command awarded a $448,244.60 firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division, a subsidiary of Thermo Electron Corporation Financial Services Division. The contract is for 0007 53GX and will provide products and/or services from October 7, 2020 through October 30, 2021 at the place of performance in Portage, Michigan. No additional details were provided regarding the original solicitation, major subcontractors, or high-level context...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the supply of PHADIA IMMUNOCAP SPEC IGE diagnostic equipment, reagents, and related services. The contract has a ceiling value of $24,960.42 and a period of performance through September 30, 2025. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in providing advanced allergy and autoimmune testing...